Tyler Golato

Tyler Golato is the Chief Scientist of Molecule, an open-source protocol for drug development. Previously, he worked at the National Institute of Aging Research (NIH/NIA/IRP) under the guidance of Dr. David M. Wilson III and Dr. Vilhelm Bohr, focusing on repairing endogenous DNA damage, especially in the context of aging. He also worked in the Robert Fine laboratory at Columbia University, researching the mechanisms of chemotherapy resistance in pancreatic cancer and developing novel therapeutic strategies for various types of cancer.